Back to Sleep: Risk factors for SIDS as targets for public health campaigns
Guido Pastore(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Andrea Guala
Cited by 7
Related Papers
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
|The Lancet|2002|552
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Prospective study of multiple sclerosis with early onset
|Multiple Sclerosis Journal|2002|152